Solvay open to offers as deadline nears
This article was originally published in Scrip
Executive Summary
Solvay is fast approaching today's deadline by which indicative bids to acquire its pharmaceutical unit must be submitted, and it is rumoured that the Belgian company might be preparing to consider some of the proposals.